SOURCE: The Bedford Report

The Bedford Report

August 27, 2010 08:45 ET

Analyst Reports on American International Group (NYSE: AIG) & Unitrin (NYSE: UTR) -- The Bedford Report Analyst Team Gives Perspective

Note to Editors: The Following Is an Investment Opinion Being Issued by The Bedford Report.

TORONTO--(Marketwire - August 27, 2010) -  The Bedford Report analyst team is looking at the Property & Casualty Insurance Industry and has issued Analyst Reports on American International Group, Inc. (NYSE: AIG) and Unitrin, Inc. (NYSE: UTR). Access to the full company reports can be found at www.bedfordreport.com

After experiencing catastrophic losses in 2008, and being rescued by massive capital injections from the government, the insurance industry has been taking steps forward on the path to recovery. In 2009, the arrest of activity in credit markets caused bond prices to drop. Property & Casualty insurers have been hit especially hard by the poor bond market. They hold as much as two-thirds of their assets in bonds, and as such are highly sensitive to credit market conditions. It is expected that weak investment portfolios and reduced income from the variable annuities, in addition to weak underwriting, will make for downside pressure on these companies in the coming months.

Like you, we realize that timing is everything. We release daily market updates so you can stay ahead of the crowd and make the best investment decisions to maximize your returns. Take a few minutes to register with us for free at www.bedfordreport.com and get exclusive access to our numerous analyst reports and industry newsletters.

The outlook for Property & Casualty Insurance companies is considered to be mixed right now, with many analysts giving ratings ranging from hold to buy for both American International Group and Unitrin. AIG in particular is a company to closely watch, and expectations are high as it continues to stabilize and restructure.

Investors can get copies of the full analyst reports on American International Group and Unitrin by registering for free at www.bedfordreport.com.

The Bedford Report has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at: http://www.bedfordreport.com/disclaimer.php

Contact Information